Source: Annual Congress 2003 - Severe pulmonary infection and sepsis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. N. Shoikhet, T. I. Martynenko, E. V. Shilova, S. V. Shabanova (Barnaul, Russia). Etiology and etiotropic therapy of angiogenic sepsis. Eur Respir J 2003; 22: Suppl. 45, 2870

Member's Comments

No comment yet.

Related content which might interest you: Immunomodulating therapy and the risk of severe pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 353s Year: 2002 The influence of inadequate starting empirical antimicrobial therapy of septic pneumonia on outcomes at patients with angiogenic sepsis Source: Eur Respir J 2004; 24: Suppl. 48, 549s Year: 2004 Corticosteroids as adjunctive therapy in tuberculosis pneumonia with ART Source: Breathe 2008; 5: 274 Year: 2009 Two-coloured magnetic-laser therapy in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 Glucocorticosteroid therapy as predisposing factor for pulmonary sarcoidosis relapse Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease Source: Eur Respir J 2006; 28: Suppl. 50, 131s Year: 2006 Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach Source: Eur Respir J 2015; 45: 1142-1149 Year: 2015 Outcomes of Fibrinolytic therapy for acute empyema. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Severe pulmonary infections due to biological therapy of rheumatic diseases Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011 Adjunctive systemic corticosteroid treatment in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Severe fibrotic lung disease – How much therapy is too much therapy? Source: Annual Congress 2008 - Clinical Grand Round - an interactive session Year: 2008 Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Efferent therapy in complex treatment of community-acquired pneumonia in patients with immunosuppression Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Immunoallergic manifestations of antituberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 505s Year: 2006 Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injury Source: Eur Respir J 2016; 47: 1219-1228 Year: 2016 Efficiency of two-colored magnetic-laser therapy in pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 375s Year: 2006 Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia Source: Annual Congress 2004 - SARS and other lower respiratory tract infections Year: 2004